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PREFACE 
Eversince the industrial revolution which led to the moderni-
zation of the world, we are constantly being forced to breathe in the 
polluted air, to drink the contaminated water and to eat the 
adulterated food. Especially, in the last three decades, there has 
been an unparalled expansion in the chemical industry as witnessed by 
the development of many new organic chemical products and increased 
product applications (Ames, 1979). 
Naturally occuring as well as synthetic steroids and alkaloids 
have been constantly used in various industries (Fishbein, 1984). 
Owing to their contact with man and their constant persistence in the 
environment, these chemicals interact with the normal metabolic 
processes occuring in the living system. Several steroids and 
alkaloids have been reported to be mutagenic and carcinogenic on the 
basis of short-term tests (DunkeL et al,. 1985). Systematic and 
thorough screening of these chemicals especially those having some 
biological activities, therefore, seems to be desirable not only for 
understanding their toxic behavior but also for understanding their 
mechanism of carcinogenesis. 
Cancer is the second largest cause of death with about one-
quarter of the population in Western Society developing malignancies. 
Epidemiological studies of different populations and of migrants 
moving from one area to another suggest the important role of 
environmental factors in the causation of cancer. Prevention of cancer 
to a significant measure thus could be possible by the appropriate 
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identification of the responsible chemical (Sobels, 1984). 
In view of the large number of compounds for screening, it is 
very difficult, rather impossible, to thoroughly test the mutagenic 
and carcinogenic potential of these biologically and industrially 
important compounds. Because of both, the involvement of high cost and 
relatively more time required for the screening of particular 
biological activity, short-term bacterial tests such as 'Ames Testing 
System' can fulfil the demand to some extent. Alkaloids and steroids^ 
because of their well-known phainiiaceutical and medicinal importance as 
well as their relationship with the promotion of neoplastic 
transformation in certain cases have been selected for their potential 
mutagenicity and carcinogenicity. 
These chemicals were easily available from the Chemistry 
Department of our University. The major objective for the synthesis of 
these chemicals was to develop pharmaceutically important compound 
having diversified type of biological activities. These chemicals 
would therefore undergo a thorough screening before they could serve 
as the potential drug. It seemed worthvdiile to test their mutagenic 
activity at the very begining. We have, therefore, carried out the 
mutagenicity testing employing Ames-testing as well as E.coli and 
lambda systems. A preliminary work was also done on the mutagen-DNA 
interaction using BND-cellulose chromatography. A detailed and 
thorough study is intented during the course of our Ph.D. work to find 
out a plausible mechanism of carcinogenesis induced by these 
chemicals. 
In the first chapter of this dissertation, review of literature 
is presented to become acquainted with the latest trends in the field 
of mutagenicity testing. 
The second chapter describes some general methodology, bacterial 
and phage strains, composition of media and buffers etc. employed 
in these investigations. 
Third chapter incorporates the data on the Ames testing of 
steroids. 
Survival of SOS defective E.coli K-12 strains, induction of 
lysogen and in vitro study employing BND-cellulose chromatography has 
been presented in the fourth chapter. 
Fifth chapter is devoted for general discussion and conclusion 
drawn from the experimental data. In the last, bibliography is 
documented. 
CHAPTER I : REVIEW OF LITERATURE 
Cancer is derived from the Greek word 'Karkinos' meaning crab. 
It is a condition resulting from the uncontrolled reproduction of 
cells. The cells in a cancer do not multiply at a faster rate than 
normal cells but they do multiply more frequently as the time between 
divisions diminishes. They escape controlling factors and eventually 
form a cluster of cells. Soon the cluster becomes an abnormal 
functionless mass of cells called a tumor. The body normally responds 
to a tumor by surrounding it with a capsule of connective tissue. Such 
a tumor is said to be benign. However, if the cells multiply too 
rapidly to be restricted, or if they break out of the capsule and 
metastasize, the tumor is described as malignant. The condition is 
now called cancer, meaning that the cells are radiating out like the 
'arms of a crab' (Alcamo, 1987). 
It is suggested that cancer essentially is increased entropy, 
randomness and disorder. The cancer cell is unable to arrest growth 
because it is unable to inactivate its glyoxalase, which destroys the 
ketone-aldehyde that keeps the cell at rest and in the radical state 
(Szent-Gyorgyi, 1977). 
One of the most striking properties of the neoplastic state is 
its heritable nature. Ihis is also true of the preneoplastic state. 
Ihe heritable nature of both the preneoplastic and the neoplastic 
state has focussed speculation that the pathogenesis of cancer 
involves permanent alterations in gene expression perhaps accompanied 
by permanent alterations in gene structure, i.e. mutation (Friedberg, 
1985^. These loosely knit concepts are embodied in the general theory 
of carcinogenesis called the somatic mutation theory (Florey, 1962; 
Lloyd-Luke et al., 1978) which dates back to observations by Boveri 
(1914) of altered nuclear morphology in cancer cells. The somatic 
mutation theory may be stated as follows: Agents that initiate 
neoplastic transformation do so by interacting with the DNA of cells, 
causing damage. The results with the Ames test strongly support the 
somatic-cell mutation theory of cancer (Flessel £tjal., 1987). 
The oncogene theory which is also a well documented one, was 
first proposed by Huebnor and Todaro in 1969. This theory suggests 
that the genes to transform a cell, the oncogenes, reside in the 
chromosomal DNA of a normal cell. When a genetic change occurs, such 
as by introduction of a virus, the oncogenes transform the cell to a 
cancer cell (Cooper, 1982; Fink, 1984). Genetic changes which 
contribute to cancer include altered gene-function, altered expression 
of genes or their loss (Ponder, 1988). 
For some years, mutations of dominantly acting oncogenes have 
been the centre of attention, but the recent description of the 
genetic events in the development of retinoblastoma has focussed 
interest once again on losses of gene function (Ponder, 1988). A 
report by Vogelstein et al (1988) of multiple genetic losses in 
colonic cancers is the latest in a series of such findings. The 
development of retinoblastoma has been shown to involve loss of both 
alleles at a single locus, mapped to the long arm of chromosome 13(13q 
14), and individuals with the hereditary forms of retinoblastoma have 
been shown to have inherited the loss of one copy of the gene in the 
germ line (Hansen and Canenee, 1988). The retinoblastoma gene is 
regarded as the prototype of a class of tumor-suppressor genes whose 
presence in normal cells is required to prevent the emergence of a 
tumor and which seem likely to have important functions in the 
regulation of normal cells, proliferation and development. 
It has long been known that cancer can arise as the result of 
exposure to a variety of agents, and studies on the mechanism of the 
induction process have revealed that pure chemicals themselves are 
able to produce cancer (Miller, 1978). Damage to WA by environmental 
mutagens may be the main cause of death and disability in advanced 
societies (Cairns, 1975b). It is believed that this damage, 
accumulating during our lifetime initiates most human cancer and 
genetic defects and is quite likely a major contributor to aging 
(Burnet, 1974) and heart disease as well (Pearson et al., 1975). 
Since a large proportion of human cancer may arise from chemical 
causes, cancer prevention will depend to a large extent upon the 
recognition and possible elimination of environmental and endogenous 
exposure to carcinogenic agents (Doll and Peto, 1981). To this end, 
surveys of available and relevant data on potential carcinogens to 
^ich man may be exposed are being published (Bowman, 1982; lARC 
Monograj^s, 1972-1984). Since some degree of exposure is unavoidable, 
particularly that arising from natural sources, effective prevention 
must also depend upon methods to prevent the development of neoplasia 
following exposure. Ultimately this may only be attainable through a 
thorough understanding of each sequential stage of the carcinogenic 
process (Saffhill et al., 1985). Rapid and accurate, in vitro tests 
such as the Salmonella/mjcrosome test, should play a crucial role in 
the identification of environmental mutagens and minimizing human 
exposures (McCann and Ames, 1976). 
Carcinogenic Agents And their Mechanism of Action 
A high proportion of human cancers are attributed to environmen-
tal agents, mainly the chemicals. Epidemiological evidence strongly 
suggests that there is a major 'environmental' factor in the occurence 
of cancer. This factor is a combination of all aspects of our 
lifestyles, including social and cultural habits, diet, agricultural 
practices and exposure to manmade pollutants. Many estimates of the 
proportions of cancers caused by specific environmental factors have 
been made (Farmer, 1982). 
It is frequently assumed that ESMA -damaging agents are 
carcinogenic because they induce mutations. However, another strong 
possibility is that the damage leads to heritable changes in the 
methylation of cytosine in EJ^ A. Considerable evidence exists that gene 
expression in mammalian cells is in part controlled by methylation of 
specific DNA sequences (Robin, 1987). Carcinogens may act by altering 
the normal epigenetic controls of gene activity in specialised cells 
and thereby produce aberrant heritable phenotypes. It is known that 
agents which inhibit DNA methylation can be carcinogenic and that 
tumor cells are altered in DNA methylation (Robin, 1987). 
One of the theories at etiology of cancer, which is being widely 
accepted, holds that the major cause is damage to DNA by 
oxygen-radicals and lipid peroxidation (Totter, 1980; Ames, 1983). 
Ihere is an increasing amount of data which suggests that chemical 
carcinogens may cause both direct Wk damage, i.e., carcinogen-DNA 
adducts, and indirect DNA damage by causing formation of free radicals 
and superoxides that react with DNA and cause molecular lesions 
(Cerutti, 1985). 
Most chemical carcinogens are alkylating or acylating agents 
(electrophilic reagents) or produce such compounds following 
metabolism in the body. This means that they have electron deficient 
centres and will combine with electron-rich centres within the cell. 
Reaction with EWA is the most important process in the initiation of 
mutagenesis and carcinogenesis, although reaction with certain 
amino-acids in proteins will also occur (Farmer, 1982). Alkylating 
agents are able to react at many sites in EWA, in particular at the 
ring nitrogen and the exocyclic oxygen atoms of the DNA bases and at 
the oxygen atoms of the phosphate internucleotide linkages (Margison 
and O'Connor, 1979; Singer and Kusmierek, 1982; Pegg, 1983). 
Substitution at the N-7 position of guanine in DNA is usually the 
major reaction product with alkylating carcinogens although many other 
products such as 3-alkyladenine, 3-alkylguanine, 0 -alkylguanine, 
alky1thymidine, 3-alkylcytosine and the exocyclic N -alkylguanine are 
also formed (Farmer, 1982). 
The majority of chemical carcinogens are known to form covalent 
adducts with DNA (Miller, 1978; O'Connor, 1981) and there is now a 
large body of evidence implicating DNA as a critical target in 
chemically induced cancer. Studies with many alkylating agents have 
indicated that it is their capacity to react with certain oxygen-atoms 
in EWA, in particular those associated with promutagenicity, v^ i^ch 
provides an indication of their carcinogenic potential (Loveless, 
1969; Saffhill, 1985). Many compounds, however, do differ in their 
extents of reaction with the EWA of various tissues ^ vivo, 
reflecting both the distribution of the compound within the animal and 
the need for some compounds to be metabolized before they can undergo 
reactions leading to the alkylation of DNA (O'Connor et al, 1979; 
Pegg, 1983). 
During the past few years it has been established that one of 
the mechanisms of chemical carcinogenesis is induction of mutation 
that "activate" the protooncogene of mammalian genomes (Meisler, 
1987). 
Certain promoters of carcinogenesis act by generation of oxygen 
radicals; this being a common property of these substances. Many 
carcinogens which do not require the action of promoters and are by 
themselves able to induce carcinogenesis also produce oxygen radicals 
(Demopoulos et al., 1980). The mechanism of action of promoters 
involves the expression of recessive genes and an increase in gene 
copy number through chromosome breaks and creation of hemizygosity 
(Varshavsky, 1981; Kinsella, 1982). Promoters also cause modification 
of prostaglandins which are intimately involved in cell-division, 
differentiation and tumor growth (Fisher et^  a]^., 1982). 
Most data on radical damage to biological macromolecules concern 
with the effects of radiation on nucleic acids because of the possible 
genetic effects (Wolff et^  al^ ., 1986). Much of the toxic effect of 
ionizing radiation damage to DNA is also due to the formation of 
oxygen radicals (Totter, 1980). 
Since virtually every chemical known to cause cancer in humans 
also causes cancer in animals (lARC Monographsm, 1972-1975; Tomatis et 
al., 1973; Epstein, 1974) the simplest assumption is that any chemical 
which is a carcinogen in an animal test is likely to be a human 
carcinogen, though, there are mapy uncertainities in determining the 
risk to humans from animal data (Epstein, 1974; Mantel and 
Schneiderman, 1975; Ames et al, 1987). In general chemicals 
carcinogenic in one species are carcinogenic in other species (lARC 
Monographs, 1972-1975; Tomatis, 1973) although the carcinogenic 
potency of a particular chemical can vary considerably depending upon 
the animal species in which it is tested and the manner in which the 
chemical is administered (lARC Monographs, 1972-1975; Weisburger, 
1973, 1975; Sontag £t al., 1975). Chemicals of very similar structure 
can also differ greatly in carcinogenic potency (McCann et al., 
1975a). 
Correlation of Carcinogenesis And Mutagenesis 
Ames test has been widely used to investigate the mutagenic 
potential because many carcinogens are also mutagenic (Flessel et al., 
1987). Although a high degree of variation was obtained with regard to 
the sensitivity of Ames test ranging from 45% to more than 90% (McCann 
et_ al., 1975b; McCann and Ames, 1976; Purchase et al., 1976; Sugiraura 
et_al., 1976; Heddle and Bruce, 1977; Levin etal., 1984; Tennant et 
al., 1987; Zeiger et al., 1987). It was also suggested that a high 
level of sensitivity is often more a characteristic of the composition 
of the test material than that of the test system (Dyrby and 
Ingvardsen, 1983 ). It is also noteworthy that as the time have 
elapsed from the first Ames test conducted by McCann et al (1975a) to 
correlate the mutagenic potential of a carcinogen upto the work of 
Tennant et al (1987) there appears a continuous decrease in the degree 
of sensitivity by Ames testing. Zeiger et al (1987) reported that the 
Ames test has a sensitivity (percentage of carcinogens identified as 
mutagens) of only 54% and a specificity (percentage of non-carcinogens 
identified as non-mutagens) of only 70%. Even worse, the same year 
Tennant et al (1987) found that the Salmonella assay would only 
identify about 45% of carcinogens. These results are at variance with 
the observations made a decade ago when sensitivities and 
specificities of 90% or more were claimed for the Ames test (McCann et 
al., 1975a; McCann and Ames, 1976). 
Nestraann (1986) stated that a mutagen is a mutagen, not 
necessarily a carcinogen. For instance caramel, a sugar derivative 
which is widely used as a food coloring and flavoring agent, is also 
mutagenic in Salmonella test system, but has no carcinogenic effect 
when fed to rats as 6% of the diet for 2 years (Evan et al., 1977). 
Cancer And WA Damage 
Damage to DNA is likely to be a major cause of cancer and other 
diseases (Hiatt et al., 1977; Ames, 1979). There is an evidence which 
support that carcinogens and radiations likely to initiate most human 
cancers and genetic defects do so by damage to DNA (McCann et al., 
1975a). Defined precisely, DNA damage is an alteration that constitute 
a stumbling block for the replication machinery and hence hampers the 
replication of WA, endangering the survival of the cell (Devoret, 
1979). 
The correlation between radiation-induced damage and cancer has 
long been apparent to radiation biologists but through molecular 
evidence it has been found that DNA damage is a direct cause of 
cancer. The evidence comes from patients suffering from xeroderma 
pigmentosum (Devoret, 1979). With certain eukaryotic cells, the 
consequences of EWA damage can also be assessed by cytogenetic 
analysis. The human disorders atoxia telangiectasia, Blooms syndrome 
and Fanconi's anemia are genetic diseases characterized by an 
increased susceptibility to cancer (Walker et al., 1985). 
Studies with Poecilia formosa showed an increased incidence of 
tumors in recipients bearing cells maintained under non-DNA repair 
conditions thereby implicating EWA damage as a specific etiological 
factor in the neoplastic transformation (Hart and Setlow, 
1975; Woodhead and Scully, 1977; Woodhead, et al., 1977). Study with 
Syrian hamster (DiPaolo and Dortovan, 1978; Doniger et al., 1981) also 
suggested a causal relation between EWA damage and neoplasia. The 
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demonstration of the photoactivation of UV-induced ovabian-resistant 
mutations in haploid frog cells in vitro adds further evidence that 
pyrimidine diraers are mutagenic lesions in vertebrates (Massey et al., 
1976). 
Mutation (or DNA damage) as one stage of carcinogenic process is 
supported by various lines of evidence: association of active forms of 
carcinogens with mutagens (Ames and McCann, 1981), the changes in EWA 
sequence of oncogenes (Weinberg, 1985), genetic predisposition to 
cancer in human diseases such as retinoblastoma (Knudson, 1985) or 
DNA-repair deficiency diseases such as xeroderma pigmentosum (Cleaver, 
1984). 
According to McCann and Ames (1976) and other evidences listed 
below, it is compelling to propose that radiations and chemical 
carcinogens cause cancer through damage to EWA (somatic mutation), (i) 
It is known that cell regulation can be altered by mutation, and that 
a heritable change in cell regulation is a characteristic property of 
a cancer cell, (ii) The theory is simple and consistent with facts in 
cancer biology (Cairns, 1975a, b) (iii) It is supported by studies on 
the genetics of cancer (Knudson, 1975). (iv) There are human mutants 
lacking DNA repair systems that are extremely prone to cancer (Cleaver 
and Bootsma, 1975). (v) There is a correlation between capacity for 
repair of DNA damage and the occurence of organ-specific cancer (Goth 
and Rajewsky, 1974; KleiLues and Margison, 1974; Nicoll et al., 1975). 
(vi) Active forms of many carcinogens are electrophiles capable of 
interacting with EWA (Miller and Miller, 1971). (vii) Almost all 
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carcinogens tested have been shown to be mutagens (McCann et al., 
1975a). (viii) Many potent aromatic carcinogens are unusually 
frameshift mutagens and the structural basis is the presence of an 
aromatic ring system capable of strong stacking interaction with ESMA 
and an electrophilic moiety (Ames and Whitfield, 1966; Ames et al., 
1972; Ames et al., 1973b). (ix) In addition to the many chemical 
carcinogens as mentioned above there is a diverse collection of 
carcinogens such as asbestos (Sincock and Seabright, 1975), metal 
carcinogens (Nishioka, 1975), and a variety of radiations that have no 
obvious connection other than their ability to damage DNA. 
DNA Repair 
DNA is the primary carrier of genetic information and the 
structural integrity of EWA is a prerequisite for gene expression 
(Modak, 1972). It is a known fact that primary structure of WA is 
dynamic and subject to a constant change (Friedberg, 1985b). Ionizing 
and UV-radiations as well as multitude of other chemical agents upset 
the genetic and metabolic machinery of the living system. That would 
perhaps render our planet barren were it not subjected to the constant 
cellular monitoring and repair. Moreover, the contemporary global 
environment also posed a continual threat to the hereditary material. 
Ihe living systems have, therefore, evolved repair processes to 
maintain stinactural and functional fidelity of EWA against a large 
range of insult (Friedberg, 1985b). The molecular mechanisms involved 
in repair of damaged portions of EWA and their restriction into 
functionally intact informational units is fundamental to the 
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maintenance of the genomic integrity (Modak, 1972). Defective DNA 
repair could cause an accumulation of lesions or mutations which might 
be either lethal, lead to an altered ptieuotype, or neoplastic 
transformation. Repair at the cellular and macromolecular level is 
multiple in its form and varies as a function of species, tissue and 
stage of the cell cycle (Hart et^  al., 1979). 
A great deal of research has been directed towards gaining new 
insights into the mechanistic regulation of repair machinery in 
Escherichia coli. The physiological studies on the recovery from WA 
damage have established the existence of DNA repair pathways. 
Moreover, the genetic studies have identified a large number of genes 
participating in the repair of damaged EWA (Walker, 1985). 
The earliest suggestion on recovery of bacteria after exposure 
to ultraviolet (UV) light was made by Hollender and Curtis in 1935. 
Later, Kelner (1949) observed that exposure of UV-irradiated bacteria 
to visible light reversed the killing and mutagenic effect of UV 
light. He coined the term 'photoreactivation'. The isolation of an 
E.coli by Hill (1958) provided the first evidence on genetic control 
of radiation sensitivity. Setlow and Carrier (1964) and Boyce and 
Howard-Flanders (1964) independently demonstrated that UV-induced 
thymine dimers in bacterial DNA were not excised in a UV-sensitive 
strain but were excised in the viild-type strain. This suggested that 
excision of thymine dimers from bacterial DNA may be important for 
cell survival and that it is genetically controlled. 
Further, the same repair system has been shown to operate on the 
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damage induced in WA by carcinogens, mutagens and other hazardous 
chemicals (Ishi and Kondo, 1975; Auerbach, 1976; Seeberg, 1981;, 
Friedberg, 1985l>). The foregoing developments paved the way for the 
systematic study of DNA repair mechanism in prokaryotes and thus led 
to the discovery of additional repair systems. The following repair 
systems have been shown to be existing in bacteria: 
Photoreactivation : The simplest class of repair pathway is 
photoreactivation that directly rectifies the cyclobutane type 
pyrimidine dimers in UV-irradiated EWA without the formation of new 
phosphodiester bonds (Walker £t al., 1985). This type of recovery 
process requires the exposure of cell to visible light. It was the 
first system to be observed in vitro (Rupert et al., 1958) and was the 
first to be characterized with regard to mechanism (Rupert, 1952a, b). 
Hiotoreactivation is a universal phenomenon because it is known to 
occur in E.coli, yeast and possibly in higher animals and plants 
(Schild et al., 1984). 
Excision Repair : An important mechanism for cell survival after 
UV-irradiation depends upon the release or excision of pyrimidine 
dimers from the DNA by excision enzjmies, and the subsequent 
reconstruction of the twin helix by repair enzymes that make use of 
the intact opposite strand as template. Excision repair appears to be 
a significant source of DNA repair virtually in all organisms (Walker 
et al., 1985). UV-induced damage in cellular DNA is also repaired in 
dark by excision repair system. Mechanism of repair of DNA by excision 
has been studied extensively using mutants of E.coli sensitive to 
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ultraviolet radiations (Setlow and Carrier, 1964; Boyce and 
Howard-Flanders, 1964; Howard-Flanders et al., 1966). 
Excision repair is the process in which the lesions in DNA are 
removed and the gaps are refilled with correct base sequences using 
the opposite intact strand as template. Excision repair enzjnnes have 
also been demonstrated to act upon the DNA damaged by chemical 
mutagens and carcinogens (Kondo et al., 1970; Miller and Heflich, 
1982). Ihis repair system could have at least four steps viz. 
incision, excision, gap filling and sealing. 
Post Replication Recombinational Repair : The DNA lesions, especially 
UV-induced pyrimidine dimers that are neither split photoenzymatically 
nor removed from EWA by excision repair, block the continuous progress 
of the DNA replication fork. However, they do not prevent the 
reinitiation of DNA synthesis at a point beyond the diraer (Rupp and 
Howard-Flanders, 1968). As a result, gaps are produced in the daughter 
strand opposite the lesions. Ihe continuity of daughter strand is 
interrupted by gaps of obout 1000 nucleotides (Howard-Flanders, 1968; 
Iyer and Rupp, 1971; Benbow et al., 1974). This type of enzymatic DNA 
repair by which the molecular weight of the newly synthesized strand 
increases is called post replication repair. Ihis was first 
demonstrated in E.coli by Rupp and Howard-Flanders (1968). 
Inducible Error prone SOS Repair : The term 'SOS' (international 
distress signal) implies to an error prone repair, induced under 
enormously stressed condition, of growth as a last resort for the 
survival of cells. The existence of 'SOS' network was clearly 
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postulated by Defais et_ al^  (1971) and was further developed and 
amplified by Radman (1974; 1975) and Witkin (1976). The exposure of 
E.coli to the agents that damage EWA or interfere with DNA replication 
results in the induction of a diverse set of physiological responses 
+ + 
called 'SOS' response. It requires recA and lexA genotypes of host 
(Muira and Tomizawa, 1968; Defais et^^l., 1971). 'SOS' repair is a 
highly integrated and sophisticated regulatory network that require de 
novo protein synthesis for expression (Kovel, 1986). It is an 
inducible repair process and is believed to be responsible for a 
conmon mutagenic pathways (Radman, 1974; Witkin, 1976; Walker, 1985). 
In response to DNA damages calling for the SOS repair, EWA repair 
systems in E.coli are activated, cell division is altered, integrated 
viruses are induced and respiration is blocked (Witkin, 1976; Little 
and Mount, 1982). 
Several bacterial genes have been identified v^ich coordinately 
function in 'SOS' repair. These are uv^and uvrB (EWA repair), umuC 
(mutagenesis), sfiA (filamentation), himA (site specific recombina-
tion) and several din genes with unknown functions in addition 
to the recA and lexA genes (Witkin, 1976; Kenyon, 1983). Role of recBC 
and recN genes has also been suggested in 'SOS' induction (Chaudhury 
and Smith, 1985; Finch £t al., 1985). 
RecA and iexA genes are the regulators which control 'SOS' 
response. Under normal conditions lexA protein represses the 
subordinate genes of the systepi and recA protein derepresses these 
loci in response to DNA damage (Kenyon, 1983). LexA protein is a self 
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repressor and also binds to similar operator sequences in each gene 
(Littlest al., 1981; Sancer jet al., 1982; Little, 1984). During 'SOS' 
induction, the lexA repressor is cleaved between ala-gly bond by the 
second regulator, the recA protein (Little, 1984). RecA protein 
acquires a specific protease activity to form recA when it interacts 
with an intracellular molecule that results from certain type of DNA 
damage and therefore, recA protein is considered to play a key role in 
the induction of 'SOS' response (Radman, 1975; Takahashi et al., 
1986). 
The 'SOS' response is transient and thus following DNA repair 
and removal of inducing stimulus (i) recA protein loses its protease 
activity, (ii) level of lexA repressor rises, and (iii) repression of 
the SOS genes resumes (Brent and Ptashna, 1981; Little et ad, 1981; 
Sancer£t al., 1982). 
The accumulation of certain deoxynucleotide monophosphates and a 
high level induction of recA gene expression have been suggested to 
stimulate the 'SOS' repair (Gottesman, 1981). Moreover, Salles et al 
(1983) reported the full amplification of recA protein without any 
amplification of other single strand binding proteins under 'SOS' 
inducing conditions. Bebenek and Janion (1985) proposed the possible 
role of mismatch repair also in the induction of 'SOS'. 
Mutagenesis resulting from 'SOS' processing of damaged DNA 
template is targeted and is not due to the induction of some random 
mutator activity (Miller, 1983; Walker, 1984). Radman (1974, 1975) 
suggested that the appearance of mutation during 'SOS' processing 
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might be due to the inducible infidelity of DNA replication, because 
pyrimidine dimers were found to block the chain elongation by purified 
DNA polymerase I and III on UV-irradiated DNA template. Subsequent 
studies revealed the involvement of inducible inhibition of proof 
reading (3'->- 5' exonuclease) activity of WA polymerases (Radman et 
_al., 1977; Boiteux _et _al., 1978; Villani _et _al., 1978). Moreover, the 
lexA dependent conversion involving theesubunit of K^A polymerase III 
holoenzyme to 'SOS' polymerase has also been postulated (Scheuermann 
_et _al., 1983; Piechocki _et _al., 1986). Lu _et ^  (1986) in fact, have 
demonstrated the recA mediated inhibition of '3 -^5' nuclease activity 
of isolated c subunit of DNA polymerase III and was suggested to be 
responsible for targeted mutagenesis. 
Theories of Chemical Carcinogenesis 
One of the major objectives of cancer research is to determine 
the molecular mechanisms by which chemical carcinogens contribute to 
the development of neoplasia. Evidence for a mutational basis of at 
least some neoplasia is provided by studies of transforming genes of 
the ras family (Yuasa et al., 1984). Activation of ras protooncogenes 
in human tumors is apparently often due to point mutations in the ras 
coding sequence. In these cases, an error-prone repair process might 
play a direct role in the initiation of cancer after exposure to a 
chemical carcinogen and error-free repair might play a direct role in 
its prevention (Walker et al., 1985). 
However, some carcinogens may act epigenetically to change gene 
expression. Certain observations are consistent with the hypothesis 
that at least some effects of chemical carcinogens are due to 
generalized effects on gene expression caused by alterations in the 
degree of cytosine raethylation. The correlation between 
hypomethylation of cytosine residues and active gene expression in 
eukaryotic cells has been well documented (Razin and Riggs, 1980; 
Ehrlich and Wang, 1981). Wilson and Jones (1983) suggested that 
alterations in specific raethylation patterns could give rise to 
oncogene transformation by activating quiescent genes. This view is 
supported by the observations that the metallothionein-1 gene is 
activated by UV-irradiation of mouse cells and that this gene 
expression is associated with extensive demethylation of the 
metallothionein-1 gene (Lieberman et al., 1983). Mechanisms by which 
DNA damage could lead to a heritable loss of raethylation pattern 
include direct modification and inactivation of the methyltransferase 
enzyme (Drahovsky and Wacker, 1975; Cox, 1980; Wilson and Jones, 1983) 
and/or slow and incomplete raethylation of deoxycytosine incorporated 
during excision-repair synthesis (Kastan et al., 1982). 
Carcinogenicity Testing Systems 
It has become increasingly apparent that the traditional methods 
for identifying carcinogens by using long-term studies in rodents are 
unable to meet demands for a quick, sure and inexpensive 
identification of environmental carcinogens. This has brought about an 
intensive search for appropriate test systeras and over the last few 
decades a series of short-term tests have been published (Dyrby and 
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Ingvardsen, 1983). 
Long-term tests, however are expensive and time consuming they 
have given considerable evidence in estimating the potency of a 
carcinogen (Farmer, 1982). But, there is a problem of predicting 
whether humans will respond to the carcinogen in the same way as 
animals (Farmer, 1982). There are several instances in which only one 
species like mouse was found to respond to the test and the rat was 
ineffective. Then how can we extrapolate the risk from rodents to 
humans, a very dissimilar long-lived species. Opposite was also found 
in v^ich a chemical was found to be carcinogenic by epidemiological 
studies but was non-carcinogenic in rodents (Ames et al., 1987). 
Short-term tests (STTs) for genotoxic chemicals were originally 
developed to study mechanisms of chemically induced DNA damage and to 
assess the potential genetic hazard of chemicals to humans. The four 
better known short-term tests are chromosome aberration, sister 
chromatid exchange, mutagenicity assay using mouse lymphoma cells and 
the Ames test. Ihe chromosome abberations are the result of effects 
that occur anywhere in the genome therefore, because of the difference 
in size between a genome and a gene, the cytogenetic effects 
manifested as gross chromosome aberration occur at a much greater 
frequency than do mutations observed at a single locus. This test has 
provided a very sensitive method for determining, whether or not 
environmental agent can interact with the genetic material (Wolff, 
1984). For the majority of chemical mutagens which are S-dependent 
agents the sister chromatid exchange (SCE) has proved to be even more 
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sensitive than the induction of aberrations. The SCEs, like chromosome 
aberrations induced by S- dependent agents, are formed by unrepaired 
lesions that are present when the cell passes through S and the 
chromosomes replicate. SCE method has been used as a test system to 
tell v^ iether or not a chemical is potentially dangerous and to 
determine which of the metabolites of a premutagenic and 
precarcinogenic agent might be the likely ones to interact with DNA 
and cause its effect (Wolff, 1984). Ashby and Tennant (1988) observed 
that no combination of the four STTs is any better than Salmonella on 
its own for flagging probable carcinogens. The role of these tests has 
increased however because of accumulating evidence in support of the 
somatic mutation theory of carcinogens (Straus, 1981; Crawford, 1985; 
Ames et al., 1987) and because of reports that many rodent carcinogens 
are genotoxic in in vitro STTs (Ames, 1979). The in vitro STTs have 
the advantage that they can be conducted relatively quickly and 
inexpensively compared to long-term carcinogenicity assays with 
rodents and do not involve testing in animals. Early studies of con 
cordance between results from in vitro STTs and rodent carcinogenicity 
tests were highly encouraging (IXirston et al., 1973; Sugimura et al., 
1976; Devoret, 1979). Sensitivities (percentages of carcinogens 
identified as mutagens) and specificities (percentages of 
non-carcinogens identified as non-mutagens) of 90% or better were 
reported, especially for the Ames Salmonella mutagenicity assay 
(McCann et al., 1975a; Purchase et al., 1976). 
Wide use of short-term tests for detecting mutagens (Ames, 1979) 
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and a number of animal cancer tests on plant substances have 
contributed to the identification of many natural mutagens and 
carcinogens in the human diet (Kapadia (ed) 1982). There is a range of 
applications in v^ich STTs have been used successfully, from the 
identification of mutagenic fractions in complex mixtures such as 
cooked meat (Hatch etal., 1984; Sugimura, 1985) or air pollutants 
(Schuetzle and Lewtas, 1986) to the early identification of genetic 
toxicity in the development of new chemical products (Tassignon, 
1985). 
On the basis of a literature-derived study of the performance of 
STTs (Waters and Auletta, 1981), it became apparent that there were 
two impediments to a thorough evaluation of the ability of these tests 
to predict rodent carcinogenicity : for most STTs there was a dearth 
of results for documented noncarcinogens (Shelby and Stasiewiez, 1984; 
Kier et_ al., 1986; Ray et al., 1987) and too few chemicals had been 
tested in multiple STTs to permit meaningful comparisons of the 
ability of different STTs and STT combinations to predict carcinogens. 
Even with a battery of assays, not all rodent carcinogens are in vitro 
mutagens nor are all in vitro mutagens rodent carcinogens. STTs do, 
however, contribute to offer an economical, rapid and dependable means 
to detect genotoxic chemicals (Tennant et al., 1987). 
Ames Testing System 
Of the various bacterial manifestations of DNA damage, Ames 
chose mutagenesis as the basis of his pioneering work to develop a 
test for potential carcinogens (Devoret, 1979). The 
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Salmonella-mutagenicity test (Ames et al., 1975), along with other 
short-term assays (Hollstein ^  al., 1979), is being extensively used 
to survey a variety of substances in our environment for mutagenic 
activities (Ames, 1984). The test measures back mutation in several 
specially constructed mutants of Salmonella. 
The test has been adapted for use in detecting chemicals which 
are potential human carcinogens or mutagens by adding homogenates of 
rat liver (or other mammalian tissue) directly to the petri-plates as 
an approximation of mammalian metabolism into the in vitro test (Ames 
et al., 1973a). Ihis test is also instrumental in understanding the 
primary events of the carcinogenic process initiated by chemicals 
(Devoret, 1979). Ihe compounds are tested on petri-plates with several 
specially constructed mutants of Salmonella typhimurium LT2 type 
selected for sensitivity and specificity in being reverted from a 
histidine requirement back to prototrophy by a wide variety of 
mutagens (Ames et al., 1973a). 
Several histidine- requiring mutants in the standard set of 
Salmonella tester strains have GC base pairs at the critical site for 
reversion e.g. -C-C-C- in the base-pair substitution strain, TAIOO 
(Barnes et al., 1982), -C-C-C-C-C-C- in the frameshift tester strain, 
TA97a (Levin et al., 1982a) and -C-G-C-G-C-G-C-G- in the frameshift 
tester strain, TA98 (Isono and Yourno, 1974), However, TA102 and TA104 
have AT base pairs at the critical site for reversion. These strains 
detect a variety of oxidants and other agents as mutagens which were 
not detected in the standard tester srains (Levin et al., 1984). 
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Steroids ; Uses And Applications 
Naturally occuring as well as synthetic steroids have been 
conmonly used in various industries (Fishbein, 1984). Most of them are 
used as medicine and pharmaceuticals (Wilpart et al., 1985). 
Homo-aza-steroidal esters are known for their antineoplastic activity 
(Pairas et^ al., 1986). Certain steroids have also been reported to 
control energy metabolism throughout pregnancy (Baird et al., 1985). 
Steroid-alkaloid formulation has been used for skin disorder treatment 
(Chain £t £l,, 1984). Moreover, some oxazoles and their derivatives 
have been reported to possess anti-inflammatory, analgesic, 
antibacterial, antimicrobial and antiviral activities (Turchi and 
Dewar, 1975). Also, there are some steroidal compounds which increase 
resistance against drugs and toxic agents (Kourounakis, 1986). It has 
been found that medroxyprogesterone acetate inhibits growth of 
hormone-dependent mammary carcinoma cells (Costa et al., 1986). 
Mechanisms of antitumor action of gestagens on endometrial cancer has 
also been investigated (Nishida et al., 1986). As pharmaceuticals, 
oxazoline are useful as antihypertensive as well as central nervous 
system regulators (Levitt, 1970 a,b). Fluorouracil-estradiol conjugate 
(Asano et al., 1978) and modified steroid-alkylating agents (Panayotis 
et al., 1983) have been reported to possess antitumor and antimutator 
activities respectively. 
Steroids As Potential Carcinogens 
There is a high risk of the development of cancer with the use 
of steroids. Several steroids have been reported to possess 
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tumorigenic and carcinogenJLc activities. Increased rate of oesophagal 
cancer has been attributed to the presence of these potentially 
carcinogenic chemicals present in our food (Allen £t£l., 1981; Kay, 
1981; Candrian^t al., 1984). 
Several steroids have been reported to be mutagenic and 
carcinogenic on the basis of short-term tests (IXinkel et al., 1985). 
Various steroids have been shown to play an active role in human 
carcinogenesis (Lipsett, 1986). Especially the steroidal hormones and 
their derivatives have been demonstrated to be mutagenic and 
carcinogenic in the bacterial as well as in the animal testing systems 
(Kay, 1981; McKillop et_a_l., 1983; Metzler, 1984). 
Estrogenic hormones have been shown to possess the tumorigenic 
activity and are assumed to serve as regulators of tumor growth. These 
hormones probably maintain the neoplastic state of the cells in a 
variety of well-characterized experimental animal tumor systems 
(Katzenellenbogen, 1986). Growth promoting effect on hepatocarcinoma 
has also been demonstrated to be mediated by estrogen-receptor in the 
male rats (Kohigashi et al., 1986). Carcinomas in ovary tumors are 
more often estrogen positive than benign tumors (Lantta and Acta, 
1984). 
The mechanism of action of steroid hormones involves their 
interaction with tissue-specific binding sites and results in a 
precise modulation of gene expression by regulating some RNA 
processing events. It has been found that the majority of the human 
primary breast tumors contained detectable levels of steroids in the 
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homogenate or cytosol fractions (Prakash et al., 1986). Tissue 
steroids have been found to play a role in regulating aromatase 
activities in breast and endometrial cancer (James et al., 1986). 
Steroid alcohol sulfotransferases have been isolated from the cytosol 
of a human breast carcinoma cell line MCF-7 (Rozhim £t £l., 1986). 
Moreover, the steriochemical complementarity of WA and reproductive 
steroid hormones have been found to correlate with biological activity 
(Lawrence £t £l., 1986). 
Contraceptive steroids have been assessed for toxicological and 
carcinogenic hazards (Heywood, 1986). Oral contraceptives are believed 
to pose a high carcinogenic risk with regards to the mammary gland and 
reproductive gland (Heywood, 1986). They have also been shown to 
enhance liver tumor in the Egyptian toad (Sadek and Abdelmeguid,1986). 
Contraceptive steroids have been shown to enhance mutagenic activity 
in Salmonella (Rao et al., 1983) and were also found to be the 
promoter of tumorous growth in rat liver (Heike et al., 1986). 
Alkaloids ; Uses And Applications 
Naturally occuring as well as synthetic alkaloids have been 
commonly used in various industries (Fishbein, 1984). Most of them are 
used as medicines and pharmaceuticals. Polyindoline alkaloids of 
Psychotriaforsteriana is currently been used in antitumor chemotherapy 
(Roth et al., 1986). Crinasiatine and phenanthridone alkaloid have 
bacteriostatic and tumor inhibiting activity (Ghosal et al., 1985). 
Chromone alkaloid and its salts have been reported to have excellant 
analgesic and iramunomodulating activity in vivo and in vitro (Vasudev 
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et al., 1985). Studies on the anticancer activities and mechanism of 
mistletoe and its alkaloids have also been proposed (Tasneera eit al., 
1986). Quinoline alkaloids are used as antibacterial agents (Willems, 
1986). Some clavine-type ergot alkaloids have been shown to possess 
antimicrobial activity against certain human pathogenic bacteria (Eich 
^ al., 1985). Indole-alkaloid derivatives have been tested for their 
antibacterial activity (Lumonadio et al., 1986). Studies of some 
medicinal plants have resulted in the isolation of a series of 
antimicrobially active indole alkaloids. Some of them are toxferine, 
secamine and ibogam-type alkaloids (Verpoorte, 1986). Some quaternary 
alkaloids are found to be responsible for the inotropic activity on 
the heart (Cave et al., 1984). Some butyrated alkaloids hydroxyanisole 
have been evaluated as protective agents against pyrrolizidine 
alkaloid toxicity in rat (Garret and Checke, 1984). On the other hand, 
pyrrolizidine alkaloids isolated from Heliotropium marifolium are 
known for their significant antitumor activity (Satish et al., 1986). 
Moreover, there are some alkaloids which are used as coloring and 
preservative agents (Osawa et al., 1981). 
Alkaloids As Potential Carcinogens 
Several alkaloids have been reported to possess tumorigenic and 
carcinogenic activities. Increased rate of oesophagal cancer has been 
attributed to the presence of these potentially carcinogenic chemicals 
present in our food (Allen et al., 1981; Kay, 1981; Candrian, 1984). 
Pyrrolizidine alkaloids are naturally occuring carcinogens and they 
have been found in some fifty species of the families Compositae, 
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Boraginaceae and Leguminosae (Schoental, 1982) which are used as foods 
or herbal remedies. Indole alkaloids from various sources have been 
reported to be tumor promoters (Fujiki £t^  aj^ * > 1983). Mutagens in 
opium pyrolyzates possibly implicated in oesofiiagal cancer have been 
characterized and identified through epidemiological and environmental 
field studies (Bartsch £t al., 1984). Moreover, several pyrrolizidine 
alkaloids and their metabolites have also been demonstrated to be 
mutagenic, carcinogenic and antimitotic in bacterial and animal 
testing systems as well as in plants (Alderson and Clark, 1956; 
Malaveille et al., 1982; Griffin et al., 1986). 
Recent Advances In Carcinogenicity Testing System 
Ashby and Tennant (1988) concluded from their survey of around 
222 carcinogens and non-carcinogens that the Salmonella assay (the 
so-called Ames test) does not identify all carcinogens. It does work 
for certain chemicals particularly those that become reactive 
electro{iiiles and attach to DNA(Miller and Miller, 1977), but it 
certainly does not work for all of them (Tennant, 1987). Moreover, 
Tennant (1987) observed that three of the better-known short-term 
tests f those for chromosome aberrations, for sister chromatid 
exchange and a mutagenicity assay using mouse lymphoma cells) although 
each was more sensitive than the Ames test,but they were all less 
specific, and therefore falsely labelled more non-carcinogens as 
probable carcinogens. He further observed that no combination of the 
four tests is any better than Salmonella on its own for flagging 
probable carcinogens. A second genotoxic assay conducted in vivo was 
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suggested by Ashby and Tennant, (1988). The test is the mouse 
micronucleus assay which reacts on cells with chemically induced 
chromosome aberrations having an unusual distribution of chromatin 
during cell division which can be observed as distinct micronuclei in 
cytoplasm. Validation of this genotoxicity assay, is likely to be of 
more use than in vitro tests which do not aid identification of 
carcinogens. 
The reliable and sensitive detection of characteristic molecu-
lar markers for human exposure to chemical carcinogens is no longer 
barrier to further study, as several sophisticated analytical 
techniques such as tandem mass spectrometry and fluorescence line-
width narrowing spectrophotometry are now available (Shuller, 1987). 
A new Salmonella mutagenicity test method is under development 
to test a chemical with more than one strain simultaneously (the 
"SIMULTEST") that is, different Salmonella typhimurium tester strains 
with R-plasmid and without plasmid are used in combination on the same 
plate. This approach may be useful in reducing the workload associated 
with mutagenicity testing with Salmonella (Nestman et al, 1987). The 
process of chemical carcinogenesis is well understood to support a 
policy distinction between genotoxic and nongenotoxic carcinogens. 
Conservative Mathematical model could account for the possibility that 
a carcinogenic chemical would "add on" to the background of cancer 
(Perera, 1988). 
Recently Ames et al (1987) have invited a great deal of 
controversy over the popular view that synthetic carcinogens are 
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posing a higher risk than the natural ones. According to this review 
carcinogenic hazards from current levels of pesticide residues or 
water pollution are likely to be of minimal concern relative to the 
background level of natural substances. However the authors have put a 
question mark on the degree of importance on the natural exposures. 
Animal models provide invaluable information in studies of 
carcinogenesis (Harris, 1985; tky, 1988). Extrapolation of this 
information from experimental animals to humans remains, however, a 
problematic endeavor. Most scientists consider the qualitative 
extrapolation to be accurate, i.e., a chemical that is carcinogenic in 
experimental animals is likely to be carcinogenic in humans. Although 
there is a positive association between adduct levels and 
tumor-initiating potency in many but not all studies using animal 
models (Wogan and Gorlick, 1985), it is not known u^ether such 
association exists in human carcinogenesis (Harris, 1985). Lifetime 
carcinogenicity studies will still be needed for those nongenotoxic 
carcinogens that are tissue, sex, species specific in contrast to the 
genotoxic carcinogens that cause tumors in different species at 
multiple sites. The latter will need only a limited bioassay (Hay, 
1988). 
Definition of the Problem and the Objectives of the M.Phil Work 
Owing to the biological activities of naturally occuring as well 
as synthetic steroids and alkaloids these compounds are extensively 
being used for their clinical trials. Moreover, the compounds with the 
steroidal and alkaloidal nuclei are already available in the market in 
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the form of medicine and other household materials and thus are coming 
in direct contact with man. It is therefore, essential to investigate 
their hazardous nature too. Increasing incidence of certain t3^es of 
occupational cancer also calls for particular attention to screen the 
potentially carcinogenic compounds present in the environment. The 
idea of the routine and systematic study of steroidal and alkaloidal 
compounds for their potentially mutagenic and carcinogenic behavior 
gains further support in view of their tumorigenic and carcinogenic 
activities. The short term assay would obviously be the first step 
forward in the direction of minimizing the exposure to the potentially 
toxic steroids, as prevention is always better than cure. 
In view of the present literature, we initiated the project on 
the diagnosis of some available steroids for mutagenicity and 
carcinogenicity employing Ames testing system. 
The major objectives were as follows : 
(i) Screening of available steroids for mutagenicity by means of 
Ames testing system (Spot-test), 
(ii) Confirmation of mutagenicity of the steroids by performing plate 
incorporation assay. The work with a single potent steroid and 
its parent compound to be included to determine the effect of 
the substituted group, 
(iii) The potent steroid to put to test by SOS repair defective 
strains of E.coli and E.coli-lambda systems, 
(iv) In vitro study to put forward a mechanism for DNA carcinogen 
interaction. 
CHAPTER II : GENERAL MATERIALS AND METHODS 
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Table 1. The Salmonella t3^himurium and Escherichia coli strains 
used in this study have been tabulated as under: 
Strain 
designation 
Relevant genetic markers Source 
TA97a 
TA98 
TAIOO 
TA102 
TA104 
AB1157 
AB2463 
AB2494 
Ames Strains 
uvrB, hisD6610, bio, rfa, 
R-factor plasmid-pkMlOl 
uvrB, hisD3052, bio, rfa, 
R-factor plasmid-pkMlOl 
uvrB, hisG46, bio, rfa, 
R-factor plasmid-pkMlOl 
uvrB, hisG428, bio, rfa, 
R-factor plasmid-pkMlOl 
multicopy plasmid-pAQl 
uvrB, hisG428, rfa, 
R-factor plasmid-pkMlOl 
E.coli K-12 strains 
thi-1, argE3, thr-1, leuB6, 
r s 
proA2, hisG4, lacYl, F, Str, ^ 
recA13, thi-1, argE3, thr-1, 
leuB6, proA2, hisG4, F, Str, A 
lexA, thi-1, thr-1, leuB6, 
proA2, hisG4, metB, lacYl, 
r s 
F, Str, A 
Ames, B.N. 
Ames, B.N. 
Ames, B.N. 
Ames, B.N. 
Ames, B.N. 
Howard-
Flanders, P. 
Howard-
Flanders -P. 
Howard-
Flanders-P. 
C600 thr, leu, thi, lac, A Thomas, R. 
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Table 2 : The strains of iysogen (ACT857/HB101) used in this study 
are tabulated as under. 
ACI857 
HBlOl 
Conditionally defective cl^  mutant. 
The strain codes for a temperature 
sensitive immunity repressor. Lytic 
cycle is operative at 42 C and lys-
ogenic at 32 C. 
pro, leu, thi, lac 
Srivastava, 
B.S. 
Srivastava, 
B.S. 
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Methods 
Maintenance and j^ rowth of bacteria : Each strain of Salmonella 
tvF^imurium was streaked over master plate. A single colony was picked 
up, grown in minimal medium and repurified by streaking over fresh 
master plate. Likewise each strain of E.coli and a lysogen was 
streaked over nutrient agar plates. A single colony was picked up and 
repurified by streaking over agar plates. The culture was tested on 
the basis of associated genetic markers raising it from a single 
colony from the master plate. Having satisfied with the test clone the 
culture was raised and streaked over minimal and nutrient agar slants. 
It was then allowed to grow 0/N at 37 C and stored at 4 C. Every month 
cultures were transferred over fresh slants with TA102 strain as an 
exception. It was transferred after every 15 days. Stabs were prepared 
for longer storage. 
Overnight culture of S^. typhimurium strains were used as such 
for experiments. Overnight culture of E.coli and lysogen were raised 
in nutrient broth at 37 C and 32 C respectively. Ihe culture was 
diluted fifty times in fresh broth followed by shaking at 37 C and 
32 C till the cell density reached to about 2 x 10^ viable counts ml"'-. 
Such exponential cultures were used in all the experiments. 
Media 
Media for Ames Strains : 
Medium for master plates and slants; The composition of the medium for 
Ames tester strains to prepare master plates and slants is as under : 
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20 ml 
15 g per 
50 ml 
10 ml 
6 ml 
3.15 ml 
0.25 ml 
910 ml 
Sterile 50 x VB Salts* 
Sterile agar 
Sterile 40% glucose 
Sterile histidine.HCl.H2O 
(2 g per 400 ml H2O) 
Sterile 0.5 mM biotin 
Sterile arapicillin solution 
(8 mg/ml 0.02 N NaOH) 
Sterile tetracycline solution''"'? 
(8 mg/ml 0.02 N HCl) 
Ihe above components were mixed with the molten agar to prepare 
the plates. ''«'<retracycline was added only for use with TA102 vv^ ich is 
tetracycline resistant. 
'fStock solution of VB salts (IX) was prepared using the 
following ingredients : 
^feso^. yH^o 0.2 g/1 
Citric acid monohydrate 2.0 g/1 
K HPO (anhydrous) 10.0 g/1 
NaHNH^P0^.4H20 3.4 g/1 
Ihe salts were added in the order indicated to warm distilled 
water and each salt was allowed to dissolve completely before adding 
the next. Ihe solution was then autoclaved for 20 min at 121 C. 
Minimal glucose plates for mutagenicity assay : 
Sterile VB salts 20 ml 
Sterile 40% glucose 50 ml 
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Sterile agar 15 g/930 ml distilled 
water 
The above components were mixed with the molten agar and then 
30 ml was poured over each plate. 
Top agar for mutagenicity assay : The top agar contained 0.6% Difco 
agar and 0.5% NaCl. 10 ml of sterile solution of 0.5 mM histidine. 
HCl/0.5 raM biotin was added to the molten agar and mixed thoroughly by 
swirling. 
0.5 mM histidine/biotin solution for mutagenicity assay ; 
I> Biotin 30.9 njg 
L- Histidine. HCl 2A.0 n^ 
Distilled water 250 ml 
Dissolve the biotin by heating the water to the boiling point. 
Then mix histidine to it. Autoclave for 20 min at 121 C. 
0.2 M sodium phosphate buffer, pH-7.4 : 
NaH PC . H O 13.8 g/500 ml 
Na^HTO 14.2 g/500 ml 
2 4 
Adjust the pH-7.4 and then sterilize it at 121 C for 20 min. 
Media for E.coli K-12 strains and lysogen : 
Nutrient broth (13 g/1) : Nutrient broth obtained from Hi-media 
(India) had the following composition : 
Peptone 5 g/1 
NaCl 5 g/1 
Beef extract 1.5 g/1 
Yeast extract 1.5 g/1 
pH (approx.) 7.4+0.2 
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In the nutrient broth obtained from Difco (U.S.A.)? NaCl was 
also added to it 
Nutrient broth 8 g/1 
NaCl 5 g/1 
Nutrient agar (Hard agar) : 
Nutrient broth 13 g/1 
(Hi-media) 
Agar powder 15 g/1 
(Hi-media) 
Soft agar : The composition of soft agar used for lysogen work is as 
under : 
Nutrient broth 13 g/1 
(Hi-media) 
Agar powder 7 g/1 
(Hi-media) 
Buffers 
MgSO . 7H 0 solution (O.OIM) ; For all dilutions, O.OIM MgSO 
solution was used. 
Buffers for BND-cellulose chromatography : 
0.3M NET buffer : For eluting unbound DNA 
0.3M NaCl 3.510 g 
lO'^M EDTA 2.0 ml 
10"2M Tris HCl 2.0 ml 
Distilled water 195 ml 
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IM NET buffer : For eluting 
1 M NaCl 
-4 
10 M EDTA 
lO'^M Tris HCl 
Distilled water 
IM NET+507„ Formamide buffer 
1 M NaCl 
10~^M ECfTA 
10~^M Tris HCl 
Formamide 
Distilled water 
double 
: For 
: stranded DNA 
eluting single 
O.OIM TNE buffer : For preparing DNA solution 
11.70 g 
2.0 ml 
2.0 ml 
196 ml 
-stranded DNA : 
11.70 g 
2.0 ml 
2.0 ml 
100 ml 
96 ml 
2 wg/ml solution of EWA was prepared in O.OIM TNE buffer. 
Chemicals 
The following chemicals were used 
Chemicals 
Agar powder 
Ampicillin 
Acetone 
3, 4- Benzo 'a' pyrene 
Biotin 
BND-cellulose 
Chloroform 
Chlorampiien ico 1 
Source 
Hi-media, India 
Ranbaxy, India 
BDH, India 
Koch-Light Ltd., England 
Nutritional Biochemical 
Corporation, U.S.A. 
Sigma, U.S.A. 
BDH, India 
Biochem Pharmaceutical 
Industries, India 
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Calf thymus DNA 
Citric acid monohydrate 
Dimethyl sulphoxide 
Dipotassium hydrogen phosphate 
(dibasic) 
Disodium hydrogen phosphate 
Ethylene diamine tetra-acetic acid 
Ethyl methane sulphonate 
Formaldehyde 
Formamide 
D- Glucose 
Histidine monohydrochloride 
Hydrochloric acid 
Hydroxyapati te 
Magnesium sulphate 
Methylmethane sulfonate 
Nutrient agar 
Nutrient broth 
Sodium ammonium phosphate 
Sodium azide 
Sodium chloride 
Sodium dihydrogen phosphate 
Sodium hydroxide 
Tetracycline 
Tris 
Sigma, U.S.A. 
BDH, India 
BDH, India 
Saraliiai,M. Chemicals, 
India 
Sarabhai, M. Chemicals, 
India 
S.d. Fine-Chem., India 
Koch-Light Ltd., England 
BDH, India 
E.Merck, India 
BDH, India 
E. Merck, Germany 
BDH, India 
Sigma, U.S.A. 
E. Merck, India 
John Baker Inc., U.S.A. 
Hi-media, India 
Hi-media, India; 
Difco, U.S.A. 
E. Merck, Germany 
Trucizna, Poland 
Sarabhai, M. Chemicals, 
India 
BDH, India 
BDH, India 
IDPL, India 
Sigma, U.S.A. 
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Steroids 
3^-Acetoxy-5<<'-cholestano (5, 6-b)-
N-fii thai imidoazir idine 
3 f-Broino-6, 6-ethylene-disulfonyl-
5 06 -cholestane 
3 ^-Brorao-5, 6-ethylene d i t h io -
5pt -cholestane 
3 P-Brorao-6, 6-ethylene- oc -sulfonyl-
p -sulfinyl-ScC.-cholestane 
3 ^-Chloro-5o<.-cholestano (5, 6-b)-
N-Phthaliraidoaziridine 
5cC-cholestane-3, 6-dione bis ethylene 
di thiolane 
3 p -Chloro-5, 6-ethylenedithio-
5 06-cholestane 
3 ^-Chloro-6, 6-ethylene-o(-sulf inyl-
^ - th io -5 ot-choles tane 
3^- Iodo-6 , 6-ethylene d i th io-5 -cholestane 
3 p -Iodo-6, 6-ethylene- oC-sulf inyl - p> -
thio-5 oL-choles tane 
3p -Iodo-6, 6-ethylene-ot-sulfonyl- /J- thio-
5 c<-choles tane 
Source 
Chemistry Department, 
A.M.U.; India 
- do -
- do -
- do -
- do -
- do -
- do -
- do -
- do -
- do -
- do -
CHAPTER III ; AMES TESTING OF STEROIDS 
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Introduction 
There is considerable evidence that a large proportion of human 
cancer may be caused by exposure to toxic chemicals in the 
environment, very few of which have been tested for carcinogenicity or 
mutagenicity. A program of cancer prevention aimed at identifying and 
eliminating human exposure to hazardous chemicals requires the 
development of rapid, inexpensive, long-term animal tests, to pinpoint 
dangerous chemicals among the thousands to which humans are exposed. 
Ihe Salmonella/microsome mutagenicity test (Ames, 1971; Ames et al., 
1973; McCann et al., 1975b) has been sufficiently developed and 
validated to be seriously considered for widespread use in this way. 
Ihe considerable evidence accumulated so far indicates that with few 
exceptions carcinogens are mutagens (Ames et al., 1973; Flessel et 
al., 1987). It thus supports the desirability of using this type of 
rapid and economical test system as a screening technique (Ames, 1971; 
Ames et al., 1973). 
Ihe work embodied in this chapter was, therefore, designed to 
screen the available cholesterol derivatives of steroids for their 
potential mutagenic and carcinogenic behavior employing Ames-testing 
system. 
Materials and Methods 
Bacteria, steroids and media are listed in Chapter II. All the 
media were freshly prepared. Two tests were routinely performed for 
testing the mutagenicity of the steroids : spot test and plate 
incorporation assay. Except otherwise stated, the cells were treated 
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for 20 minutes following the preincubation procedure in case of plate 
incorporation assay. 
Spot test : This test is the simplest way to test compounds for 
mutagenicity and is useful for the initial rapid screening of large 
number of compounds. This is a variation of the plate incorporation 
test in which the test chemical (steroid) was left out of the soft 
agar overlay and was applied directly to the surface of the minimal 
agar plate after it had been seeded with the bacterial tester strain. 
Appropriate concentrations of the steroids were added to the agar 
surface. 
A positive result in a spot test was generally not considered to 
be an adequate evidence for mutagenicity. Mutagenicity was therefore 
confirmed by quantitative plate incorporation test. 
Plate incorporation assay : This test was performed by combining the 
steroid, the bacterial tester strain and 0.2M phosphate buffer 
(pH-7.4) in soft agar which was poured onto a minimal agar plate. 
Positive and negative controls were also included in each assay. After 
incubation at 37 C for 48 hours, revertant colonies were counted and 
mutation frequency was then calculated by subtracting the spontaneous 
mutation from induced mutation. 
Routine examination of the bacterial background lawn resulting 
from the trace amount of histidine added to the top agar aided in 
determining the toxicity of the test chemical and in the 
interpretation of results. 
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Results 
Ames spot test of certain steroids : Table 2 depicts the characte-
ristic reversion patterns of the standard strains of some test 
steroids. In view of the qualitative assessment of the sensitivity of 
the tester strains, the number of revertants scored per spot for TA104 
was found to be the maximum. All the steroids that were tested 
exhibited some amount of mutagenic activity in the tester strains but 
ACPIA, BEDSC, CCPIA, CESTC and lESiTC exhibited relatively greater 
number of revertants as compared to other steroids. 
Dose response relationship test of all the steroids that were 
diagnosed in the spot test was performed. BEDSC and ACPIA showed the 
highest number of revertants per plate as compared to other steroids. 
Except the BEDSC and its parent compound, BEDTC, data of other 
steroids are not shown. BEDSC was selected for further studies. 
3p-Bromo-6, 6-ethylenedithio 5PC -cholestane (BEDTC) induced reversion 
of Ames tester strains : Reversion pattern of BEDTC with TA98, TA102 
and TA104 at various concentrations is shown in Fig. 3. This steroid 
is more active in TA104 as compared to TA102 and TA98. It showed a 
significant level of mutagenicity with TA104 at very low dose (0.25 
Mg/plate). The reversion property declined very sharply beyond this 
concentration. Similar declining trend was also observed with TA102. 
However, it showed a sharp decline beyond the dose of 0.5 ;jg/plate. 
The dose level of BEDTC was not at all lethal for TA98. It followed 
about a linear dose response pattern. Ihe tester strains can be 
sequenced in order of their responsiveness with the steroid as 
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follows : TA104>TA102>TA98. 
3^-Bromo-6, 6-ethylenedisulfonyl 5oC-cholestane (BEDSC) induced rev-
ersion of Ames tester strains : Fig. 4 depicts the reversion pattern 
of tester strains at various concentrations as a result of BEDSC 
treatment. Again, the mutant TA 104, harboring a multicopy plasmid, pK 
MlOl was the most responsive strain. This strain is reverted many 
times more efficiently by BEDSC as compared to other steroids (data of 
other steroids not shown). BEDSC also showed a significant level of 
mutagenicity with TA104 at very low dose of 0.5 ;jg/plate but beyond 
the concentration of IQug the reversion property showed a sharp 
decline. 
BEDSC also induced a positive response in an ochre mutant, 
TA102 in being reverted at such low doses as 0.5 ;ug/plate v^ile it 
showed a sharp decline beyond the dose of 15 jug/plate. This steroid 
demonstrated a linear dose- response at levels that are not 
excessively toxic to the frameshift mutants, TA97a and TA98 and a 
base- substitution mutant, TAIOO. These tester strains could be 
sequenced in order of BEDSC induced mutagenesis as follows : 
TA104>TA102>TA97a>TA98>TA100. 
Discussion 
The Salmonella test was first validated in a study of 300 
chemicals most of which were known carcinogens (McCann et al., 1975a; 
McCann and Ames, 1976; McCann and Ames, 1977). It was subsequently 
employed in other studies by the Imperial Chemical Industries 
(Purchase £t al., 1976), and the International Agency for Research on 
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Cancer (Bartsch ^ al., 1980). Nearly 90% of the carcinogens tested 
were found to be mutagenic in these studies, but there was 
considerable overlapping of chemicals tested. It is customary to 
define the compound as negative if none of the tester strains responds 
with and without metabolic activation upto the limit of toxicity, not 
exceeding to 5 mg/plate concentration (deSerres and Ashby, 1981; Dyrby 
and Ingvardsen, 1983). An increase in the number of colonies (over the 
number of spontaneous background revertants) indicates that the 
chemical is mutagenic while the number of revertant colonies provides 
an index of the mutagenic activity of the sample (deSerres and Ashby, 
1981; Levin etal., 1984; Flessel et al., 1987). Our results indicated 
an invariable increase in number of revertant colonies with all the 
test steroids. Moreover, all the steroids exhibited a remarkable 
degree of mutagenicity with TA104 and TA102 strains (Table 2). 
Table 1 shows the relevant genetic and biochemical markers of 
the Ames tester strains. All the strains carry the pK MlOl plasmid 
which is believed to enhance the error-prone repair process 
(Shenabruch and Walker, 1980; Levin £t al., 1982a). TA97a strain has 
been recommended for detecting frameshift mutagens (Levin et al., 
1982a), whereas TA102 is known to detect the oxidative mutagens (Levin 
_et _al., 1984). TA97a, TA98 and TAIOO tester strains contain G-C base 
pairs at the critical site for reversion (Isono and Yourno, 1974; 
Barnes et_al., 1982; Levin £t al., 1982a). With regard to the 
individual difference among the G-C specific mutants,TA97a, TA98 and 
TAIOO, the first two strains are the frameshift type while TAIOO is 
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the base-pair substitution mutant (Isono and Yourno, 1974; Barnes et 
al., 1982). The tester strain, TA102, is proficient in the excision 
repair machinery but carries a mutation in hisG428 gene on the 
multicopy plasmid, pAQl. On the contrary, TA104 carries the same 
mutation on the chromosome but carries a defective excision repair 
gene, uvrB which obviously diverts the repair towards the errorprone 
side and thus enhances the mutagenic activity of the compound (Levin 
et al., 1982b). In view of our findings, it is noteworthy that the 
test steroids preferentially act on the A-T base pair mutants, TA102 
and TA104 as compared to those having G-C base pairs at the site of 
mutation. However, the steroid, lESiTC seems to revert the frameshift 
tester strain, TA97a, more efficiently as compared to base-pair and 
transition mutants (Table 2). 
We have then, concentrated our studies on two steroids only, 
the parent steroid, BEDTC and its oxygenated derivative, BEDSC. Infact 
the parent, BEDTC presumably contained the reactive S-CH,~CFL-S moiety 
which was chemically converted into O^S-CH^-CH^-SOj^in the BEDSC (Figs. 
1, 2). Quantitative Ames testing of the steroids revealed that the 
tester strains, TA104 and TA102 happened to be the most responsive. 
Moreover, a strong mutagenic activity was observed with the derivative 
as compared to its parent compound (Figs. 3, 4). In view of the 
present findings it is clear that the steroid treatment brought about 
a transition mutation owing to the error-prone repair of the damaged 
cell. This idea further gains support by the relatively strong 
mutagenic response of the test compound on the uvrB defective, TA104 
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strain. 
According to Tennant et al (1987) the carcinogenic compounds 
containing the electrophiles only would be detected as mutagens by the 
Salmonella test. The electrophilic portion of the molecule is an 
electron-deficient region present either because of the particular 
structure of a chemical, or as a result of metabolic activation. Ihis 
electrophilic region accepts electrons from nucleic acids in WA, 
allowing the chemical to react and combine with it, leading to 
mutation. The test derivative of steroid being oxygenated, acts as 
electrophile and can accept single electron to yield the sulfonyl 
radical(Figs. 1, 2). The radical might, in turn, react directly with 
DNA or generate oxygen radicals like'0„, 'OH and'O". With regard to the 
mutagenic potency of the test steroids, both the criteria seem to have 
been fulfilled as were laid down by Ames and Whitfield (1966), Ames et_ 
al (1972) and Creech et_al_(1972). According to the authors the 
compound should have a ring system capable of stacking interaction 
with WA as well as should also contain an electrophilic group that 
can react with it. 
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Table 1. Relevant genetic and biochemical markers. 
S.No. Markers TA97a TA98 TAIOO TA102 TA104 
1. 
2. 
3. 
Type of mutation 
Location of 
mutation in 
histidine gene 
Excision-repair 
Frame- Frame-
shift shift 
his01242 hisD3052 
4UvrB AUvrB 
Base 
pair 
substi-
tution 
hisG46 
<au\T:B 
Transi-
tion 
hisG428 
Uchre 
mutation 
on a 
multicopy 
plasmid, 
pAQl 
uvrB 
Profici-
ent 
Transi-
tion 
hisG428 
on the 
chromos-
ome 
extra 
AUvrB 
4. Loss of polysacc- rfa 
haride layer (rfa) 
rfa rfa rfa rfa 
5. R-factor plasmid pk MlOl pK MlOl pK MlOl pK MlOl pK MlOl 
pAQl 
6. 
7. 
8. 
9. 
Base-pairs at the GC 
site of reversion 
Antibiotic Amp^ 
resistence 
Spontaneous 90-180 
reversion frequency 
Replacement of TA1537 
the strains 
GC 
Amp 
30-50 
TA1538 
GC 
Amp 
120-200 
TA1535 
AT 
AmpT, 
Tet^ 
240-320 
— 
AT 
Amp 
350+75 
" 
Symbols : ^ - deletion 
r - resistent 
Fig. 1. 3^-Bromo-6, 6-ethylene dithio 5PC-cholestane (BEDTC) 
M.P. 140 C. 
Fig. 2. 3^-Bromo-6, 6-ethylene-disulfonyl 5oc-cholestane (BEDSC) 
M.P. 167 -168 C. 
Table 2. Ames spot test of certain steroids. 
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S.No. Steroids Amount S9 TA97a TA98 TAIOO TA102 TA104 
spotted 
(>ug) 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
9. 
10. 
11. 
ACPIA 
BEDSC 
BEDTC 
BESSC 
CCPIA 
CDBED 
CEDTC 
CESTC 
lEDTC 
lESiTC 
lESoTC 
5-15 
-do-
-do-
-do-
-do-
-do-
-do-
-do-
-do-
-do-
-do-
+ 
+ 
N.D. 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
N.D. 
+ 
+ 
N.D. 
N.D. 
+ 
N.D. 
+ 
+ 
++ 
N.D 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
++ 
++ 
+ 
+ 
Sjonbols for the number of revertants/spot (Spontaneous subtracted) : 
- = ^ Control; + = ^ 10 - 30; + = 31 - 50; 
++ = 51 - 120; N.D. = not done. 
All the steroids were dissolved in acetone/dimethylsulphoxide mixture. 
5(D 
Fig 3. Dose-respopse curves of BEDTC with Ames tester strains 
TA97a : N.D. 
TA98 : O O 
TAIOO : N.D. 
TA102 : if- i(: 
TA104 : A • 
5 10 
BEDTC ( j u g / p l a t e ) 
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Fig 4. Dose-response curves of BEDSC with Ames tester strains. 
TA97a : • • 
TA98 : 0 0 
TAIOO : ^ <> 
TA102 : * ^ 
TA104 : • A 
1000 
9 0 0 h 
8 0 0 h 
700h 
UJ 
t -
< 
a. 
cr 
UJ 
Q. 
lO 
h-
Z 
< 
1 -
Q: 
Hi 
> UJ 
Q: 
600 
500 
AOO 
300 
200 
100 
BEDSC (^ig / p l a t e ) 
CHAPTER IV : ROLE OF SOS REPAIR AND MUTAGENESIS IN BEDSC - INDUCED 
INJURY : IN VIVO AND IN VITRO STUDIES 
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Introduction 
Various physical and chemical environmental agents have been 
shown to damage cellular EWA in vivo. The capacity of a system to 
repair such damage is basic to the ability of an organism to withstand 
the biological consequences of environmental stress. Correctly 
repaired, genetic damage has little effect on the biological function 
of a system. Studies of microorganisms, raaimialian and plant cells have 
shown that DNA damage results in change in the physiological processes 
such as growth, division, transcription of DNA, cell death, mutation 
and induction of transformation (Elkind and Whitmore, 1967; Price and 
Makinodan, 1973; Lohraan and Bootsma, 1974). 
E.coli responds to DNA damage with the expression of a set of 
functions usually termed as SOS response. Ihis includes the induction 
of a transitory mutagenic DNA repair system, the activation of 
inducible propiiage and of several other functions involved in cell 
division and DNA metabolism (Radman, 1974; Witkin, 1976). 
The in vitro studies on the minor distortions or changes in the 
secondary structure of DNA have been studied employing several 
techniques. The BND-cellulose chromatography has been used to measure 
the growing points in a replicating CNA (Scudiero and Strauss, 1974) 
and to detect in vitro post-replication repair. The method of 
detection of post-replication repair relies on the ability of the 
column to absorb DNA containing single stranded regions (Brash and 
Hart, 1978). 
The work embodied in this chapter was, therefore, planned to 
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estimate the extent of injury produced, to understand the mutagenic 
behavior and the mode of interaction of steroid, BEDSC with DNA. 
Our contention was that SOS defective strains of E.coli K-12 as 
well as lysogen might serve as a convenient model for this purpose 
because even a slight change in environment could be reflected in its 
survival and plague forming capacity. Also, in vitro studies with 
BND-cellulose chromatography might serve as a good tool in the 
understanding of the mechanism of DNA destabilization induced by the 
test steroid at different molar ratios. 
Materials and Methods 
Bacteria, the lysogenic strain, media, test steroid, BEDSC and 
buffer are listed in Chapter II. Relevant genetic markers associated 
with the strains is also given in Chapterll. Survival patterns of 
E.coli strains, induction of prophage X and in vitro study employing 
BND-cellulose chromatography have been studied in the presence of 
BEDSC. 
The SOS defective E.coli strains and lysogen were treated with 
that concentration of BEDSC at which the highest peak was observed in 
the Ames test as well as with the concentration three times that to it 
with lysogen only to identify the genes involved in this system. 
Except otherwise stated, the E.coli cells were treated for 6 hours. 
All the media were freshly prepared. 
BEDSC treatment to bacteria : The SOS defective recA and lexA 
mutants of E.coli K-12 as well as the isogenic wild-type strain were 
harvested by centrifugation from exponentially growing culture ( 1 - 3 
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X 10 viable counts ml" ). The pellets so obtained were suspended 
directly in 0.01 M MgSO solution and treated with the steroid. 
Samples were withdrawn at regular intervals, suitably diluted and 
plated to assay the colony forming ability. Plates were incubated 0/N 
at 37 C. Treated controls were also run simultaneously. 
Prophage induction : Exponentially grown lysogen Acl857/HB101 (1-4 x 
10 cells ml^ ) was centrifuged, suspended in 0.01 M MgSO buffer, 
treated with steroids separately and incubated at 32 C for 3 hours. 
Ihe cells were again centrifuged, washed and resuspended in nutrient 
broth and incubated for the next 3 hours at 32 C. Aliquots were taken 
out at regular intervals, suitably diluted and plated with C600 cells. 
Ihe plaques were scored after 0/N incubation of plates at 42 C. 
Treated controls were also run simultaneously. 
BND-Cellulose Chromatography : A slurry of BND-cellulose was prepared 
in 0.3 M NET buffer and the fines were removed by decantation. The 
resin was regenerated following the standard procedure which 
constitutes the stepwise washing with water (50ml per 6 gm of resin), 
0.3 M NET buffer, 50% formamide in 1 M NET buffer and finally with 0.3 
M NET. Ihe washed resin resuspended in 0.3 M NET was poured into the 
column of 1 cm diameter containing glass-wool at the bottom so as to 
achieve a column length (bed height) of 4 cm. Ihe column was 
equilibrated 0/N with 0.3 M NET buffer. Calf thymus DNA was purified 
over BND-cellulose column of the commercial sample to complete native 
DNA. Ihe 1 M NET eluate was dialyzed against 0.01 M TNE and used to 
study the effect of BEDSC on dsEWA. After regeneration and 0/N 
55 
equilibration of BND-cellulose with 0.3 M NET, 250^g DNA was treated 
0/N at 37 C with 1:0.5 and 1:1 molar ratios of the steroid and then 
subjected to binding to BND-cellulose. A control was also run 
simultaneously. Stepwise elution of DNA with the following buffers in 
the given order was carried out i.e. 0.3 M NET, 1 M NET and 1 M 
NET+50% formamide buffers. 7-10 fractions of each buffer were 
collected at the rate of 10-12 ml/hr. DNA eluted in various fractions 
was determined spectrophotometrically at 260 nra. 
Results 
Effect of BEDSC on the SOS defective E.coll strains : The survival 
patterns of recA and lexA mutants of E.coli are shown in Fig. 1. The 
damage brought about in the cell in the presence of the steroid is 
much pronounced. Both the mutants invariably exhibited a significant 
decline in their colony forming ability as compared to their wild-type 
counterpart. LexA mutant was found to be more sensitive as compared to 
recA mutant. 
Prophage induction in the presence of BEDSC : Table 1 shows the 
induction of prophage as a result of BEDSC treatment to lysogen during 
the post treatment liquid holding in the nutrient broth. A fraction of 
the lysogenic population exhibited induction of lytic cycle during the 
liquid holding at 32 C. Moreover, on increasing the concentration of 
the steroid, the fold induction was also increased. There was no 
significant increase in the prophage induction over and above the 
background level in the control as well as in the chloramphenicol 
supplemented samples. 
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BND-cellulose chromatography : The elution patterns of untreated and 
BEDSC treated WA in the BND-cellulose column are shown in Fig. 2. O/N 
incubation of steroid with the EWA at 37 C caused adherence to 
BND-cellulose indicating the production of single-stranded regions or 
breaks in the native dsDNA molecules. An increasing degree of EWA 
hydrolysis was observed with the enhancement in the steroid : DNA base 
pair ratio. The percent of DNA adhered on the BND column in case of 
0.0:1.0, 0.5:1.0 and 1.0:1.0 molar ratios were 55.29%, 55.49% and 
60.71% respectively. 
The untreated and steroid treated EWA at different molar ratios 
were eluted out in two major peaks but the area covered in the two 
peaks are remarkably different under the treated and control 
conditions. The amount of dsDNA eluted out at 1 M NET buffer in terms 
of decreasing order of area were as follows : 0.0:1.0 0.5:1.0 
1.0:1.0 whereas the peak-area eluted out at 1 M NET+50% formamide 
buffer presumably containing the ssDNA followed the reversed order. 
Discussion 
Cellular DNA damage occurs following exposure to ultraviolet 
light, ionizing radiation, various environmental chemicals and 
reactive oxygen species. If left uncorrected, it can result in cell 
death, mutation and neoplastic transformation. Prokaryotes and 
eukaryotes have evolved systems for reversing LWA damage, and several 
classes of EWA repair enzjmies have been identified (Friedberg and 
Bridges, 1983). 
The steroid (BEDSC) which was detected to be the most potent 
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mutagen in our case in the Ames testing system was also tested with 
SOS-repair defective recA and lexA mutants of E.coli K-12. It is 
postulated that the inducible error-prone repair pathway could 
potentially operate on all types of lesions in EWA whether produced by 
radiation or by other agents (Walker, 1985). These mutants were found 
to be highly sensitive to the test steroid, BEDSC (Fig. 1) suggesting 
thereby the damage to the WA of the exposed cells as well as the role 
of recA and lexA genes to cope with the hazardous effect of the test 
steroid. The role of recA and lexA gene in initiating the error-prone 
repair in E.coli is well documented (Witkin, 1976; Walker, 1985). Ihis 
idea gains further support from the prophage induction (Table 1) and 
by Ames testing studies (Figs. 3, 4) with the Salmonella strains 
triggering the error-prone SOS response. Propiiage induction infact, 
has also been used to detect the mutagenic activity of chemicals 
(Moreau et al., 1976). 
Our BND-cellulose chromatograj^ic studies suggested the enhance-
ment in the single-strandedness in the steroid-treated WA (Fig. 2). 
This finding alongwith the elevated mutagenic response of the compound 
with uvrB defective Salmonella strains (Chapter III) further supports 
the idea of physical distortion brought about by the test steroid, 
uvr endonuclease has been shown to act upon any sort of physical 
distortion in the WA rather than the pyrimidine dimers only (Braun 
and Grossman, 1974; Seeberg, 1981; Miller and Heflich, 1982). 
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Fig. 1. Survival of SOS defective E.coli K-12 strains exposed to 
BEDSC. 
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Table 1. Induction of A prophage on BEDSC treatment 
8 
Time of incubation Prophage induction per 10 lysogens 
in nutrient broth (hr) • 
Control After BEDSC treatment for 3 hrs 
0.5;jg/ml 1.5;ag/ral In presence 
of chloram-
phenicol 
(lOOjug/ml) 
0 1.0 1.0 1.0 1.0 
1 0.9 1.6 1.7 1.0 
2 1.2 1.8 3.3 1.0 
3 1.3 2.5 3.9 1.0 
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Fig. 2. BND-cellulose chromatography of double stranded calf 
thymus ENA treated with BEDSC with respect to DNA 
base-pair : compound molar ratio. 
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CHAPTER V : GENERAL DISCUSSION 
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Ames testing system has gained a world-wide recognition to 
assess the mutagenic potential of great variety of synthetic and 
natural chemicals present in our environment (Ames, 1984). Although 
the validity of the test has been questioned in terms of the actual 
carcinogenic behavior of the test compound yet a remarkable amount of 
correlation was obtained with several mutagenic compounds tested by 
the Salmonella system (McCann et al., 1975; Purchase et al., 1976; 
Flessel et al., 1987). 
Several steroids were found to have a great potential in 
pharmacology, medicine and other biochemical industries (Wilpart, 
1986). On the other hand these chemicals have also been reported to be 
mutagenic, carcinogenic and teratogenic on the basis of short-term and 
long-term testing systems (Lucier and Rambaush, 1983; Metzler, 1984; 
Dunkel et al.,1985). Interestingly enough, the compounds which we have 
selected for our studies have also exhibited a significant level of 
mutagenic activity with the Ames tester strains (Table 2, Figs. 3, 4; 
Chapter III). It is noteworthy that even in the absence of S^ 
9 
microsomal fraction, usually all the tester strains responded to a 
remarkable extent. It does not, however, essentially imply that these 
steroids would display a higher degree of mutagenicity after being 
metabolized in the higher system. 
It is always emphasized that a single testing system does not 
reflect the actual behavior of the test compound and a battery of 
various types of tests is recommended (Maron and Ames, 1983; Tennant 
et al., 1987). We have, therefore, employed other systems like the 
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E.coli and lambda for the steroid 3p-bronio-6, 6-ethylene disulfonyl-5t>c 
-cholestane. This steroid exhibited the toxicity towards the 
SOS-defective E.coli K-12 recA and lexA strains. The sensitivity of 
these radiation sensitive mutants also supports the notion that 
DNA-damage is induced by the test compound (Fig. 1; Chapter IV). The 
potential of test compound for inducing the SOS response was also 
confirmed by the significant degree of>.-prophage induction in the 
iysogenic E.coli strain (Table 1; Chapter IV) as well as the intense 
mutagenic response with the TA104 Salmonella tester strain. 
The test compound, BEDSC which is the sulfonyl derivative of 
BEDIC Figs. 1, 2; Chapter III) seems to have initiated the 
SOS-response with the concomittent induction of transition mutation 
because of the presence of a multicopy plasmid(s) in the TA104 and 
TA102 strains. TA104 strain carries a defective uvrB gene in addition 
to the pKMlOl plasmid which is believed to enhance the error-prone 
DNA-repair process (Shanabruch and Walker, 1980; Levin et al., 1982b). 
Ihe uvrB gene is involved in the error-proof machinery. The defect in 
this error-proof machinery would further lead to the enhancement of 
the error-prone repair response. 
We were also interested in the role of several chemical groups 
and positions in the steroid nucleus to have an idea about the 
contribution of different loci and moieties within the molecule 
towards the mutagenic potential of the compound to put forward a 
plausible mechanism of DNA-mutagen interaction. It was found that the 
replacement of sulphur at the 6th position of the steroid nucleus by 
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the sulfonyl group (Figs. 1, 2j Chapter III) resulted in the 
tremendous increase in the mutagenic activity of the compound (Figs. 
3, 4; Chapter III). 
One of the theories on the etiology of cancer holds that the 
major cause induced by the carcinogen is the damage to HJA by oxygen 
radicals and lipid peroxidation (Totter, 1980; Ames, 1983). Several 
enzjmies in the living system like xanthine oxidase and peroxidase, are 
thought to produce superoxide anion (' 0") during the oxidation of 
their substrates (Faria et^  al., 1977; Buttner et al., 1978). Numerous 
substances such as reduced flavins and ascorbic acid on auto-oxidation 
produce superoxide anion. This radical further accepts an electron 
from a reducing agent such as thiol to yield peroxide (H„0 ). There is 
in vitro evidence that H^O^then reacts with certain chelates of copper 
and iron to form the highly reactive free radical ("OH) (Wolff et al., 
1986). Actual appearance of superoxide anion in metabolism is 
confirmed by the ubiquitous occurence of superoxide disrautase. Our 
test compound 3^bromo-6, 6-ethylene disulfonyl-5o(.-cholestane (BEDSC), 
owing to have a disulfonyl moiety has a great potential to form the 
oxygen radical and/or reactive free radicals ('(M) and (' 0^) under the 
experimental conditions. 
With regard to the overall damage on the DNA molecule brought 
about by the test compound, the BND-cellulose chromatographic studies 
suggested the enhancement in the single strandedness in the DNA 
molecule (Fig. 2; Chapter IV). It is an established fact that recA 
protein binds to the single-stranded regions formed by any means and 
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thus is thought to initiate the SOS response (Salles and Defais, 
198A). 
In view of the high sensitivity of recA and lexA strains of 
E.coli as well as significantly high mutagenic activity of the test 
steroid with Ames testing system it is clear that : 
(i) The damage is primarily at the level of DNA. 
(ii) The injured cells cope with the situation employing both the 
constitutive as well as the inducible DNA repair machinery. 
(iii) Under the drastic conditions e.g. at relatively high dose, 
mutation is brought about by the genetic defect in the error-
proof repair system, 
(iv) With regard to the plausible nature of lesion, it seems that 
distortion in DNA occurs as a result of steroid interaction 
which is supported by genetic studies as well as with BND-
cellulose chromatography. The cell,owing to the multiple genetic 
defects and relatively lethal action of the steroid under the 
experimental conditions has no option but to initiate the SOS 
response. 
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Future Plan 
We would like to extend our studies on the following lines : 
1. Quantitative screening of available steroids to construct the 
complete dose-response curves. 
2. Mutagenicity testing of the potent compound(s) employing the 
E.coli and A-systems as well as the Mud systems. 
3. Genotoxicity testing employing sister chromatid exchange (SCE). 
4. Studies on the possible nature of potentially mutagenic lesion in 
DNA employing (i) BND-cellulose chromatography (ii) hydroxyapatite 
chromatography (iii) melting profile and (iv) alkaline hydrolysis. 
5. (i) QSAR studies on the possible mode of interaction with EWA of 
the steroid(s) exhibiting the transition mutation, 
(ii) QSAR studies on the possible mode of interaction with ENA of 
the steroid(s) exhibiting the frameshift mutation. 
6. Identification of the region/sequences, if any, with the DNA for 
preferential binding of the test steroids. 
7. Studies on the role of several light and heavy chemical moeities 
and of different positions of the parent nuclei to ascertain the 
contribution towards mutagenic potential of the compound. 
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